Active, Not Recruiting
Alflutinib Mesylate Versus Gefitinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLAG)
NCT03787992
- Conditions
- Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non-small Cell Lung Cancer
- Locations
-
- cancer hospital Chinese academy of medical sciences Beijing, China